A dramatic decrease in serum hepcidin-25 levels was observed after 4 months in patients treated with ETA or ADA, combined with methotrexate, and a significant improvement in anemia was noted (p < 0.05) [39]. This evidence concerns the gene HAMP and anemia (phenotype).